Stocks Health care USAQ
OTC · Health careQHSLab, Inc. (USAQ)
QHSLab, Inc. brought in $3M of revenue over the twelve months to June 30, 2026, up 24.6% from a year earlier. Net income was $524.1K, a net margin of 17.4%. At June 30, 2026 it held $317.4K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
Watch USAQ in 60 secondsWhat QHSLab, Inc. does
QHSLab, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker USAQ.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.7M | $457.4K | $0.02 | n/a |
| 2024 | $2.1M | -$259.2K | -$0.03 | n/a |
| 2023 | $1.4M | -$468.4K | -$0.05 | n/a |
| 2022 | $1.2M | -$996K | -$0.11 | n/a |
| 2021 | $1.4M | -$770.2K | -$0.10 | n/a |
| 2020 | $124.5K | -$327.4K | -$0.05 | n/a |
Full financial statements: income, balance sheet and cash flow
Where USAQ ranks in Health care
Latest SEC filings
What QHSLab, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 17, 2026Passive stake (5% or more) SCHEDULE 13G
- September 10, 2026Passive stake (5% or more) SCHEDULE 13G
- September 4, 2026Activist stake changed SCHEDULE 13D/A
- August 12, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 40% to $847.5K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- August 3, 2026
- June 17, 2026
- May 26, 2026
- May 14, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 13% to $728.7K versus the same quarter last year; diluted EPS $0.00 versus -$0.01.
- April 27, 2026Activist stake (5% or more) SCHEDULE 13D
- April 21, 2026
Insider trades
What the people running QHSLab, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 26, 2026 | Marvin Smollar Family Trust dtd 2/13/202310% owner | Other change | 2,226,280 | - |
Who owns USAQ
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Nicholas Peters13G, passive | 8.65% | February 25, 2026 |
| Jeremy L. Smollar Irrevocable Trust dtd 2/13/202313G, passive with 1 related filers | 7.4% | September 17, 2026 |
| Justin B. Smollar Irrevocable Trust dtd 2/13/202313G, passive with 1 related filers | 7.4% | September 10, 2026 |
Largest institutional holders
Insiders
Questions about USAQ
What does QHSLab, Inc. do?
QHSLab, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker USAQ.
Is QHSLab, Inc. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $524.1K on revenue of $3M, a net margin of 17.4%.
How much revenue does QHSLab, Inc. make?
Over the twelve months to June 30, 2026 QHSLab, Inc. reported revenue of $3M. That is 24.6% more than a year earlier.
When did QHSLab, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake (5% or more) from September 17, 2026.
Similar companies
Compare USAQ with
Follow USAQ
Get an email when QHSLab, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow USAQ: get an email when it filesWhere the numbers come from
Financial figures are the values QHSLab, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.